Nrc Health (NRC) EPS (Weighted Average and Diluted) (2010 - 2026)

Nrc Health has disclosed EPS (Weighted Average and Diluted) across 17 years of filings, most recently posting $0.14 for Q1 2026.

• EPS (Weighted Average and Diluted) for Q1 2026 came in at $0.14, down 44.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $49.88 (up 4742.72% YoY), and the FY2025 annual result was $50.0, up 4707.69% from the prior year.
• EPS (Weighted Average and Diluted) came in at $0.14 for Q1 2026 at Nrc Health, down from $49.57 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $49.57 in Q4 2025 to a low of -$0.01 in Q2 2025.
• The 5-year median for EPS (Weighted Average and Diluted) is $0.28 (2023), against an average of $3.16.
• Peak annual rise in EPS (Weighted Average and Diluted) reached 17603.57% in 2025, while the deepest fall reached 103.85% in 2025.
• Nrc Health's EPS (Weighted Average and Diluted) stood at $0.27 in 2022, then jumped by 33.33% to $0.36 in 2023, then declined by 22.22% to $0.28 in 2024, then surged by 17603.57% to $49.57 in 2025, then plunged by 99.72% to $0.14 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at $0.14 (Q1 2026), $49.57 (Q4 2025), and $0.18 (Q3 2025), per Business Quant data.